drug protocol number

CICL670F2201

drug sponsor

Novartis

drug study

Deferasirox / Defearisox new formula

drug trial site

King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase